Monoclonal antibodies are produced using a technique called hybridoma technology. This involves fusing a specific antibody-producing B-cell with a myeloma cell, creating a hybrid cell line that can produce large quantities of a single type of antibody. These monoclonal antibodies can then be used to detect specific antigens in various assays.
